The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019
Open Access
- 29 February 2020
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 24 (4) , 289-294
Abstract
Excessive activation of the tissue renin–angiotensin system through angiotensin II (Ang II) type 1 receptor (AT1R) plays a pivotal role in the pathogenesis of hypertension and related organ injury. AT1R-associated protein (ATRAP/Agtrap) was identified as a molecule specifically interacting with the carboxyl- terminal domain of AT1R. The results of in vitro studies showed that ATRAP suppresses Ang II-mediated pathological responses in cardiovascular cells by promoting AT1R internalization. With respect to the tissue distribution and regulation of ATRAP expression in vivo, ATRAP is broadly expressed in many tissues as is AT1R including kidney. The results of in vivo study employing genetic engineered mice with modified ATRAP expression showed that ATRAP inhibits cardiovascular injuries provoked by Ang II-induced hypertension, along with preserving physiological AT1R signaling. In addition, we have shown that ATRAP functions as an endogenous modulator so as to prevent hypertension in response to pathological stimuli, by regulating renal sodium handling. Furthermore, ATRAP may have an AT1R-independent function of renal proximal tubule to protect aging and fibrosis. These results suggest the clinical potential benefit of an ATRAP activation strategy in the treatment of hypertension and cardiorenal and vascular diseases.Keywords
This publication has 31 references indexed in Scilit:
- Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused miceAmerican Journal of Physiology-Renal Physiology, 2010
- Molecular determinants of angiotensin II type 1 receptor functional selectivityJournal of Molecular and Cellular Cardiology, 2009
- Pharmacologic Perspectives of Functional Selectivity by the Angiotensin II Type 1 ReceptorTrends in Cardiovascular Medicine, 2008
- Novel Regulatory Effect of Angiotensin II Type 1 Receptor-Interacting Molecule on Vascular Smooth Muscle CellsHypertension, 2007
- The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and functionCurrent Hypertension Reports, 2007
- Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular systemAmerican Journal of Physiology-Cell Physiology, 2007
- Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 ReceptorJournal of Biological Chemistry, 2006
- Renin-dependent Cardiovascular Functions and Renin-independent Blood-Brain Barrier Functions Revealed by Renin-deficient MiceJournal of Biological Chemistry, 2000
- Cloning and Characterization of ATRAP, a Novel Protein That Interacts with the Angiotensin II Type 1 ReceptorJournal of Biological Chemistry, 1999
- Intracellular Trafficking of Angiotensin II and its AT1and AT2Receptors: Evidence for Selective Sorting of Receptor and LigandMolecular Endocrinology, 1997